Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 AUD | 0.00% | 0.00% | -27.03% |
May. 28 | PainChek Granted Patent in 20 European Nations | MT |
Apr. 23 | PainChek Secures AU$1,210,000 R&D Tax Incentive | MT |
Sales 2022 | 994K 658K | Sales 2023 | 1.96M 1.29M | Capitalization | 32.45M 21.46M |
---|---|---|---|---|---|
Net income 2022 | -5M -3.31M | Net income 2023 | -7M -4.63M | EV / Sales 2022 | 28.7 x |
Net cash position 2022 | 6.14M 4.06M | Net cash position 2023 | 2.51M 1.66M | EV / Sales 2023 | 15.3 x |
P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-4.26
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.56% |
Current month | -6.90% | ||
1 month | -10.00% | ||
3 months | -6.90% | ||
6 months | -27.03% | ||
Current year | -27.03% |
Managers | Title | Age | Since |
---|---|---|---|
Philip Daffas
CEO | Chief Executive Officer | - | 16-09-29 |
Iain McAdam
DFI | Director of Finance/CFO | - | 21-03-21 |
Andrew Hoggan
COO | Chief Operating Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Murray
CHM | Chairman | 65 | 16-09-29 |
Ross Harricks
BRD | Director/Board Member | 79 | 16-09-29 |
Adam Davey
BRD | Director/Board Member | - | 14-09-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 0.027 | 0.00% | 981,677 |
24-06-13 | 0.027 | 0.00% | 2,728,633 |
24-06-12 | 0.027 | 0.00% | 661,230 |
24-06-11 | 0.027 | -3.57% | 733,986 |
24-06-07 | 0.028 | +3.70% | 205,400 |
Delayed Quote Australian S.E., June 13, 2024 at 11:58 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.03% | 29.33M | |
+31.02% | 384B | |
+25.31% | 222B | |
+3.13% | 146B | |
+15.67% | 58.33B | |
+19.47% | 34.08B | |
+0.72% | 28.9B | |
+27.57% | 21.73B | |
+3.03% | 13.61B | |
-9.89% | 13.14B |
- Stock Market
- Equities
- PCK Stock